Effectiveness of Instrument Assisted Soft Tissue Mobilization in Management of Piriformis Syndrome
Launched by RIPHAH INTERNATIONAL UNIVERSITY · May 6, 2024
Trial Information
Current as of August 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a treatment called Instrument Assisted Soft Tissue Mobilization (IASTM) to see how effective it is for women with Piriformis Syndrome. Piriformis Syndrome is a condition that causes pain in the buttocks and can affect the sciatic nerve, leading to discomfort when sitting, standing, or lying down. The trial aims to understand if IASTM can help reduce pain, improve movement, decrease disability, and enhance the overall quality of life for those affected by this condition.
To participate in the study, women aged 30 to 65 who have been diagnosed with Piriformis Syndrome may be eligible. They should experience pain related to the sciatic nerve and show specific signs during physical tests. However, individuals with certain health issues, such as severe trauma, infections, or specific back problems, cannot join the study. Participants can expect to receive the treatment and will help researchers learn more about how IASTM can benefit those with Piriformis Syndrome. This study is particularly important as there is limited research on this treatment in Pakistan.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed patients of Piriformis syndrome.
- • Only females will be included in this study.
- • Participants aged 30-65 years.
- • Pain due to non-discogenic sciatic nerve entrapment in sub gluteal space.
- • Pain aggravated by prolonged sitting, lying, standing.
- • Positive FAIR test, Pace sign, Laseque sign, Beatty maneuver and Freiberg test.
- • Negative Kemp sign, Milgram's test, Bowstring test, Braggard test and Lasegue differential test.
- Exclusion Criteria:
- • Patients with any Intrinsic Etiology such as Haemarthrosis, rheumatoid arthritis or infection.
- • Patients with any recent severe trauma, fractures, subluxation or ligament injury.
- • Malignancy, Open wound Fracture, DVT, Compartment syndrome, Pregnancy.
- • Patients with irreversible nerve damage.
- • Patients with lumbar disc herniation or any disc pathology.
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rawalpindi, Punjab, Pakistan
Patients applied
Trial Officials
Ramsha Tariq, Masters
Principal Investigator
Senior Lecturer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported